Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

2030 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Apollomics Announces Approval of Vebreltinib in China as a First-in-Class Treatment for Gliomas with MET Fusion Gene
GL
Certain A Shares of Shanghai Urban Architecture Design Co., Ltd. are subject to a Lock-Up Agreement Ending on 20-APR-2024.
CI
Apollomics Presents Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting
GL
Fu Yu : Annual Report (FU-YU-COR-AR2023)
PU
Apollomics Highlights Clinical Progress and Reports Full Year 2023 Financial Results
GL
Apollomics Highlights Clinical Progress and Reports Full Year 2023 Financial Results
AQ
Transcript : China Overseas Land & Investment Limited, 2023 Earnings Call, Mar 28, 2024
Certain A Shares of Yunnan Botanee Bio-Technology Group Co.LTD are subject to a Lock-Up Agreement Ending on 25-MAR-2024.
CI
Transcript : Karat Packaging Inc., Q4 2023 Earnings Call, Mar 14, 2024
Apollomics Appoints Matthew Plunkett, Ph.D. as Chief Financial Officer
GL
Apollomics Appoints Matthew Plunkett, Ph.D. as Chief Financial Officer
AQ
Head of Alibaba's Struggling Food-Delivery Unit Steps Down
DJ
Dongjiang Environmental Company Limited Announces Executive Changes
CI
Apollomics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
GL
Certain A Shares of EMTEK Co., Ltd. are subject to a Lock-Up Agreement Ending on 28-JAN-2024.
CI
China Suntien Green Energy Corporation Limited Announces Change of President
CI
Apollomics to Participate in a Fireside Chat at the B. Riley Securities’ 2024 Virtual Oncology Conference
GL
Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia
GL
Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia
AQ
China's new thirst for coffee spurs cut-throat cafe competition
RE
EHang’s Certified EH216-S Pilotless Passenger-Carrying Aerial Vehicles Debut Commercial Flight Demonstrations in Guangzhou and Hefei
GL
Landmark 10th edition of the PropertyGuru Asia Property Awards (Mainland China, Hong Kong, Macau) elevates preeminent developers, designers
AQ
Apollomics Presents Interim Data from Two Ongoing Phase 2 Clinical Trials with Vebreltinib in NSCLC Patients with MetExon14 Skipping Mutation
GL
Apollomics Presents Interim Data from Two Ongoing Phase 2 Clinical Trials with Vebreltinib in NSCLC Patients with MetExon14 Skipping Mutation
AQ
Certain A Shares of Jiangsu Canopus Wisdom Medical Technology Co.,Ltd. are subject to a Lock-Up Agreement Ending on 30-NOV-2023.
CI
Apollomics to Participate in a Fireside Chat at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference
GL
Shuttle Inc. Announces Resignation of Members of Remuneration Committee
CI
Apollomics Announces the First Approval of Vebreltinib for MET Exon 14 Skip Non-Small Cell Lung Cancer
GL
Apollomics Announces the First Approval of Vebreltinib for MET Exon 14 Skip Non-Small Cell Lung Cancer
AQ
Transcript : Karat Packaging Inc., Q3 2023 Earnings Call, Nov 09, 2023
Utopia. NYC Exhibition | the shape of things to come: Exploring a Utopian Vision of the Future through Art and Technology
AQ
Certain A Shares of Rumere Co.,Ltd. are subject to a Lock-Up Agreement Ending on 28-OCT-2023.
CI
Apollomics Announces Report of Activity of Vebreltinib in Glioblastoma Multiforme (GBM) with PTPRZ-MET Fusion
GL
Apollomics Announces Efficacy of Vebreltinib in NSCLC Patients with MetEx14 Skipping Mutation Achieving an Overall Response Rate (ORR) of 75%
GL
Apollomics Announces Presentations of Vebreltinib Data at ESMO 2023
GL
WeTrade Group Inc. Official Announcement for the Change of Board of Directors and Senior Management
PR
WeTrade Group, Inc. Clarifies on Official Announcement for the Change of Board of Directors and Senior Management
CI
WeTrade Group Inc. Official Announcement for Clarification
PR
Apollomics Reports First Half 2023 Financial Results and Provides Corporate Update
AQ
Ningxia Xiaoming Agriculture & Animal Husbandry Co.,Ltd Announces Board Appointments
CI
Golden Star Acquisition Corporation Announces Entering into a Merger Agreement with Gamehaus Inc.
AQ
Certain A Shares of Shanxi Huaxiang Group Co., Ltd. are subject to a Lock-Up Agreement Ending on 18-SEP-2023.
CI
China needs more than cheaper mortgages to revive spending
RE
Taiwan parties battle for younger voters as high-stakes elections loom
RE
Karat Packaging to Present at Lake Street’s 7th Annual Best Ideas Growth Conference, September 14
GL
Karat Packaging to Present at Lake Street’s 7th Annual Best Ideas Growth Conference, September 14
AQ
GBT Technologies : A qualitative study that explores the implementation of artificial intelligence in integrated circuit design - Form 8-K
PU
Grand Baoxin Auto Group Limited Announces Executive Changes
CI
Grand Baoxin Auto Group Limited Announces Executive Changes
CI
New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Elderly Patients Undergoing Gastrointestinal Surgery
BU
No results for this search
  1. Stock Market
  2. Advanced search
  3. Guo Yu
  4. News